Matthew Kalnik
2012 - Biota Pharmaceuticals
In 2012, Matthew Kalnik earned a total compensation of $1.3M as Former Sr. Vice President, Strategic Planning & Business Operations at Biota Pharmaceuticals, a 81% increase compared to previous year.
Compensation breakdown
| Salary | $189,218 |
|---|---|
| Other | $1,067,922 |
| Total | $1,257,140 |
Kalnik received $1.1M in other compensation, accounting for 85% of the total pay in 2012.
Kalnik also received $189.2K in salary.
Rankings
In 2012, Matthew Kalnik's compensation ranked 5,230th out of 11,487 executives tracked by ExecPay. In other words, Kalnik earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,230 out of 11,487 | 55th |
Division Manufacturing | 1,828 out of 4,253 | 57th |
Major group Chemicals And Allied Products | 437 out of 1,198 | 64th |
Industry group Drugs | 286 out of 920 | 69th |
Industry Biological Products, Except Diagnostic Substances | 48 out of 160 | 70th |
Source: SEC filing on October 1, 2013.
Kalnik's colleagues
We found two more compensation records of executives who worked with Matthew Kalnik at Biota Pharmaceuticals in 2012.